Thiamylal: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
No edit summary
Line 1: Line 1:
{{drugbox |
{{Drugbox
| IUPAC_name       = 5-pentan-2-yl-5-prop-2-enyl-2-sulfanylidene-1,3-diazinane-4,6-dione
| verifiedrevid = 470606310
| IUPAC_name = 5-allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1''H'',5''H'')-dione
| image = ThiamylalSVG.svg
| width = 100
 
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|international|thiamylal}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule III
| legal_UK = <!-- GSL        / P      / POM / CD / Class A, B, C -->
| legal_US = Schedule III
| legal_status = 
| routes_of_administration = 
 
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = Hepatic
| elimination_half-life = 14.3 h (cats)
| excretion = 
 
<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 77-27-0
| ATCvet = yes
| ATC_prefix = N01
| ATC_suffix = AF90
| PubChem = 3032285
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01154
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2297298
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 01T23W89FR
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D06106
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 9536
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 440
 
<!--Chemical data-->
| C=12 | H=18 | N=2 | O=2 | S=1
| molecular_weight = 254.35 g/mol
| smiles = O=C1NC(=S)NC(=O)C1(C(C)CCC)C\C=C
| InChI = 1/C12H18N2O2S/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)
| InChIKey = XLOMZPUITCYLMJ-UHFFFAOYAG
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H18N2O2S/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XLOMZPUITCYLMJ-UHFFFAOYSA-N
| synonyms = Thiamylal, Thioseconal, Surital
| synonyms = Thiamylal, Thioseconal, Surital
| image            = thiamylal.png
| width            = 100
| CAS_number        = 77-27-0
| ATC_prefix        =
| ATC_suffix        =
| PubChem          = 3032285
| DrugBank          =
| C = 12 | H = 18 | N = 2 | O = 2 | S = 1
| molecular_weight  = 254.35 g/mol
| bioavailability  =
| protein_bound    =
| metabolism        =
| elimination_half-life =
| excretion        =
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      =  <!-- A / B            / C / D / X -->
| pregnancy_category= 
| legal_AU          =  <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA          = Schedule III
| legal_UK          =  <!-- GSL        / P      / POM / CD / Class A, B, C -->
| legal_US          = Schedule III
| legal_status      =
| routes_of_administration =
}}
}}


'''Thiamylal''' (Surital) is a [[barbiturate]] derivative invented in the 1950s. It has [[sedative]], [[anticonvulsant]] and [[hypnotic]] effects, and is used as a strong but short acting sedative. Thamylal is still in current use, primarily for induction in [[surgical]] [[anaesthesia]] <ref> Hsieh MY, Hung GY, Hsieh YL, Chang CY, Hwang B. Deep sedation with methohexital or thiamylal with midazolam for invasive procedures in children with acute lymphoblastic leukemia. Acta Paediatrica Taiwan. 2005 Sep-Oct;46(5):294-300. </ref> or as an anticonvulsant to counteract side effects from other anaesthetics. <ref> Tsai CJ, Wang HM, Lu IC, Tai CF, Wang LF, Soo LY, Lu DV. Seizure after local anesthesia for nasopharyngeal angiofibroma. Kaohsiung Journal of Medical Sciences. 2007 Feb;23(2):97-100. </ref> It is the Thiobarbiturate anologue of [[secobarbital]].
'''Thiamylal''' ('''Surital''') is a [[barbiturate]] derivative invented in the 1950s. It has [[sedative]], [[anticonvulsant]], and [[hypnotic]] effects, and is used as a strong but short acting sedative. Thiamylal is still in current use, primarily for induction in [[surgical]] [[anaesthesia]] <ref> Hsieh MY, Hung GY, Hsieh YL, Chang CY, Hwang B. Deep sedation with methohexital or thiamylal with midazolam for invasive procedures in children with acute lymphoblastic leukemia. Acta Paediatrica Taiwan. 2005 Sep-Oct;46(5):294-300. </ref> or as an anticonvulsant to counteract side effects from other anaesthetics.<ref> Tsai CJ, Wang HM, Lu IC, Tai CF, Wang LF, Soo LY, Lu DV. Seizure after local anesthesia for nasopharyngeal angiofibroma. Kaohsiung Journal of Medical Sciences. 2007 Feb;23(2):97-100. </ref> It is the thiobarbiturate analogue of [[secobarbital]].


== References ==
== References ==
{{reflist|2}}
<references />


{{pharma-stub}}


{{barbiturates}}
{{Sedatives}}
{{GABAAR PAMs}}


[[Category:Barbiturates]]
[[Category:Sedatives]]
[[Category:Thiobarbiturates]]
[[Category:Thiobarbiturates]]
[[Category:Anesthetics]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Anticonvulsants]]
 
[[de:Thiamylal]]
 
{{WikiDoc Sources}}
{{nervous-system-drug-stub}}

Revision as of 20:28, 10 April 2015

Thiamylal
File:ThiamylalSVG.svg
Clinical data
SynonymsThiamylal, Thioseconal, Surital
AHFS/Drugs.comInternational Drug Names
ATCvet code
Legal status
Legal status
Pharmacokinetic data
MetabolismHepatic
Elimination half-life14.3 h (cats)
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H18N2O2S
Molar mass254.35 g/mol
3D model (JSmol)
  (verify)

Thiamylal (Surital) is a barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant, and hypnotic effects, and is used as a strong but short acting sedative. Thiamylal is still in current use, primarily for induction in surgical anaesthesia [1] or as an anticonvulsant to counteract side effects from other anaesthetics.[2] It is the thiobarbiturate analogue of secobarbital.

References

  1. Hsieh MY, Hung GY, Hsieh YL, Chang CY, Hwang B. Deep sedation with methohexital or thiamylal with midazolam for invasive procedures in children with acute lymphoblastic leukemia. Acta Paediatrica Taiwan. 2005 Sep-Oct;46(5):294-300.
  2. Tsai CJ, Wang HM, Lu IC, Tai CF, Wang LF, Soo LY, Lu DV. Seizure after local anesthesia for nasopharyngeal angiofibroma. Kaohsiung Journal of Medical Sciences. 2007 Feb;23(2):97-100.


Template:Sedatives Template:GABAAR PAMs


Template:Nervous-system-drug-stub